MetaCap

Faeth Therapeutics Statistics

NASDAQ: FTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.88-0.81 (-9.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Faeth Therapeutics by the numbers

Faeth Therapeutics has a market capitalization of $203.7 million based on 25.84M shares outstanding. With trailing EPS of $-22.50, Faeth Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 64.3% below its 50-day average and 69.0% below its 200-day average.

Average daily trading volume is 500.25K shares, or about $3.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

FTH valuation vs. peer median

FTH compared with the median of 8 peer companies
MetricFTHPeer medianDifference
Market cap$203.65M$199.89M+2%
Avg. volume500.25K533.19K-6%

Peer median across 8 companies: BCYC, DRUG, VNDA, NGEN, CYPH, BIOA, YARW, ACIU.

Valuation

Price and trading

Previous close
8.69
Open
8.52
Day range
7.85 – 9.13
52-week range
7.45 – 42.14
52-week change
-9.64%
Beta
—
Volume
419.09K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
203.65M
Forward Pe
-2.15
Eps
-22.50
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
42.14
Week52 Low
7.45
Avg Volume
500.25K
Shares Outstanding
25.84M
Ma50
22.10
Ma200
25.42
Earnings Date
Nov 3, 2026
Pct From52w High
-81.30%
Pct From52w Low
5.77%

Related